Late T-lymphocyte and monocyte activation in coronary restenosis. Evidence for a persistent inflammatory/immune mechanism?;Linfocitos T y monocitos activados en la reestenosis coronaria. ¿Reflejan la persistencia de un mecanismo inflamatorio?

Revista Espanola de Cardiologia

Volumn 56, Issue 5, 2003, Pages 465-472

  Navarro López, Francisco ^a   Francino, Antonio ^a   Serra, Antonio ^a   Enjuto, Montserrat ^a   Reverter, Juan Carlos ^a   Jimenez de Anta, Teresa ^a   Betriu, Amadeo ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Coronary angioplasty; Infection; Interleukins; Leukocytes; Lymphocytes; Restenosis

Indexed keywords

CD11B ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CD64 ANTIGEN; CYTOMEGALOVIRUS ANTIBODY; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CHLAMYDOPHILA PNEUMONIAE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ELECTIVE SURGERY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; INFECTION; INFLAMMATION; LEUKOCYTE ACTIVATION; MAINTENANCE THERAPY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL VEIN; POSTOPERATIVE PERIOD; RESTENOSIS; T LYMPHOCYTE ACTIVATION;

EID: 18844481383     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13047011     Document Type: Article

References (32)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;40:115-26.
2. Moreno PR, Bernardi VH, López-Cuellar J, Newell J, McMellon C, Gold HK, et al. Macrophage infiltration predicts reestenosis after coronary interventions in patients with unstable angina. Circulation 1996;94:3098-102.
3. Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. In-Stent reestenosis: contribution of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998;31:224-30.
4. Piek JJ, Van der Wal AC, Meuwissen M, Koch KT, Chamuleau SAJ, Teeleing P, et al. Plaque inflammation in restenotic coronary lesions of patients with stable and unstable angina. J Am Coll Cardiol 2000;35:963-7.
5. Pietersma A, Kofflard M, De Wit EA, Stijnen T, Koster JF, Serruys PW, et al. Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment. Circulation 1995:91:1320-5.
6. Inoue T, Sakai Y, Morooka S, Hayashi T, Takayanagi K, Takabatake Y. Expression of polimorphonuclear leukocyte adhesion molecules and its clinical significance in patients trested with percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1996;28:1127-33.
7. Liuzzo G, Buffon A, Biasucci LM, Caliguri G, Vitelli A, Altamaura S, et al. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation 1998;98:2370-6.
8. Linkoff AM, Kereiakes DJ, Mascelli MA, Deckelbaum LI, Barnathan ES, Patel KK, et al. Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization. Circulation 2001;104:163-7.
9. Buffon A, Liuzzo G, Biasucci I. Preprocedural serum levels of C-reactive protein predict early complications and late reestenosis aftrer coronary angioplasty. J Am Coll Cardiol 1999;34:1512-21.
10. Gottsauner-Wolf M, Zasmeta G, Hornykewycz M. Plasma levels of C-reactive protein after coronary stent implantation. Eur Heart J 2000;21:1152-8.
11. Libby P, Schwartz D, Brogi E, Taanaka H, Clinton SK. A cascade model for reestenosis: a special case for atherosclerosis progression. Circulation 1992;86(Suppl III):47-52.
12. Ramires JAF, Higuchi ML. Micoplasma pneumoniae y Chlamidia pneumoniae se asocian con la inflamación y la rotura de las placas coronarias ateroscleróticas. Rev Esp Cardiol 2002;55(Supl 1):2-9.
13. Zhou YF, Leon MB, Waclawiw MA, Popma JJ, Yu ZX, Finkel T, et al. Association between prior cytomegalovirus infection and the risk of reestenosis after coronary atherectomy. N Engl J Med 1996;335:624-30.
14. Bermejo García J, Martinez P, Martin Rodríguez JF, de la Torre Carpente M, Bustamante Bustamente R, Guerrero Peral AB, et al. Inflamación e infección en la enfermedad coronaria estable y en el síndrome coronario agudo. Rev Esp Cardiol 2001;54:453-9.
15. Merino Otermin A, Artaiz Urdaci M, Bregada García J, Riera Sagrera M, Vidal Salvá B, Rodríguez Fernández A. El eptifibatide reduce los valores de proteína C reactiva tras angioplastia coronaria. Rev Esp Cardiol 2002;55:186-9.
16. Blum A, Sclarosvsky S, Shohat B. T lymphocyte activation in stable angina pectoris and after percutaneous transluminal coronary angioplasty. Circulation 1995;91:20-2.
17. De Servi S, Mazzone A, Ricevuti G, Fioravanti A, Bramucci E, Angoli L, et al. Granulocyte activation after coronary angioplasty in humans. Circulation 1990;82:140-6.
18. Ikeda H, Nakayama H, Oda T, Kuwano K, Yamaga A, Ueno T, et al. Neutrophil activation after pecutaneous transluminal coronary angioplasy. Am Heart J 1994;128:1091-8.
19. Neumann FJ, Ott I, Gawaz M, Puchuer G, Schömig A. Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty. J Am Coll Cardiol 1996; 27:819-24.
20. Serrano C, Ramires JAF, Venturinelli M, Arie S, D'Amico E, Zweier JL, et al. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecules expression. Evidence of inflammatory responses in coronary angioplasty. J Am Coll Cardiol 1997;29:1276-83.
21. Mazzone A, DeServi S, Ricevuti G. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 1993;88:358-63.
22. Haught WH, Mansour M, Rothlein R, Kishimoto TK, Mainolfi EA, Hendricks JB, et al. Alterations in circulating intercellular adhesion molecule-1 and L-selectin: further evidence for chronic inflammation in ischemic heart disease. Am Heart J 1996;132:1-8.
23. Neri Serneri GG, Prsco D, Maretini F, Gori AM, Brunelli C, Poggessi L, et al. Acute T-cell activation is detectable in unstable angina. Circulation 1997;95:1806-12.
24. Van der Waal AC, Piek JJ, de Boeor OJ, Koch KT, Teeling P, van der Loos CM, et al. Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes. Heart 1998;80:14-8.
25. Van der Wal AC, Das PK, Bentz van de Berg D, van der Loos CM, Becker AE. Atherosclerotic lesions in humans. In situ immunophenotypic análisis suggesting an immune mediated response. Lab Invest 1988;61:166-70.
26. Emeson EE, Robertson AL Jr. T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis. AM J Pathol 1988; 130:369-76.
27. Liuzzo G, Angiolillo DJ, Buffon A, Rizzello V, Colizzi C, Ginnetti F, et al. Enhanced response of blood monocytes to in vitro lipopolysaccharide-challenge in patients with recurrent unstable angina. Circulation 2001;103:2236-43.
28. Blum A, Vardinon N, Kaplan G, Laniado S, Yust I, Burk M, et al. Autoimmune and inflammatory responses may have an additive effect in postpercutaneous transluminal coronoary angioplasty reestenosis. Am J Cardiol 1998;81:339-41.
29. Caliguiri G, Luizzo G, Biasucci LM, Maseri A. Immune system activation follows inflammation in unstable angina: pathogenic implications. J Am Coll Cardiol 1998;32:1295-304.
30. Liuzzo G, Kopecky SL, Frye RL, O'Fallon M, Maseri A, Goronzy JJ, et al. Perturbation of the T-cell repertoire in patients with unstable angine. Circulation 1999;100:2135-9.
31. Caligiuri G, Paulsson G, Nicoletti A, Maseri A, Hansson GK. Evidence for antigen-driven T-cell response in unstable angina. Circulation 2000;103:1114-9.
32. Pasceri V, Yeh ETH. A tale of two diseases. Atherosclerosis and rheumathoid arthritis. Circulation 1999;100:2124-6.